Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Procaps Group ( (PROCF) ) has shared an update.
On December 5, 2025, the shareholders of Procaps Group, S.A. approved a resolution to change the company’s name to Sofgen Pharma S.A. during an extraordinary general meeting. This name change reflects a strategic rebranding effort as the company continues to operate under its existing legal and operational framework. The meeting also authorized the delegation of powers to directors for necessary actions related to the name change. Additionally, during the annual general meeting held on the same day, shareholders acknowledged conflicts of interest in certain financial transactions and approved an increase in share capital, removing preferential rights for existing shareholders to allow issuance to accredited investors.
More about Procaps Group
Average Trading Volume: 675
Technical Sentiment Signal: Sell
Current Market Cap: $57.83M
For detailed information about PROCF stock, go to TipRanks’ Stock Analysis page.